# Hydroxyzine Pamoate

NDC: 61919-880
Generic name: Hydroxyzine Pamoate
Labeler / Manufacturer: Direct_Rx
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20190603

FDA application: ANDA087479

## Active ingredients

- HYDROXYZINE PAMOATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61919-880"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61919-880
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a7084e0-530c-607b-e053-2a95a90a229c